Annals of hematology

Keyphrases

Publications

volume 103, number 9, 2024

Ying Cui
From treatment-centric to patient-centric: integrating social support and health assessments for better outcomes. Annals of hematology 103 (9) (2024)
Alexander Denk, Cornelia Mittermaier, Daniela Weber, Matthias Fante, Sibel Güneş, Matthias Edinger, Wolfgang Herr, Daniel Wolff
Efficacy and safety of ruxolitinib in the treatment of chronic graft-versus-host disease: a retrospective analysis. Annals of hematology 103 (9) (2024)
Yanlu Du, Ying Zhang, Xiaowei Xu, Yu Cai, Yu Wei, Chongmei Huang, Jun Yang, Huiying Qiu, Jiahua Niu, Kun Zhou, Xinxin Xia, Chang Shen, Yin Tong, Baoxia Dong, Liping Wan, Xianmin Song
Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide-based regimen for prevention of graft-versus-host disease in haploidentical peripheral blood stem cell transplantation for pediatric patients with hematologic malignancies. Annals of hematology 103 (9) (2024)
Sara Pellegrino, Davide Origlia, Erica Di Donna, Martina Lamagna, Roberta Della Pepa, Fabrizio Pane, Silvana Del Vecchio, Rosa Fonti
Coefficient of variation and texture analysis of 18F-FDG PET/CT images for the prediction of outcome in patients with multiple myeloma. Annals of hematology 103 (9) (2024)
Wanying Liu, Xiaojian Zhu, Yi Xiao
Neurological involvement in hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Annals of hematology 103 (9) (2024)
Keiki Nagaharu, Eiko Ohya, Yoko Edahiro, Yoshinori Hashimoto, Tomoki Ito, Akihiko Gotoh, Mika Nakamae, Fumihiko Kimura, Michiaki Koike, Keita Kirito, Hideho Wada, Kensuke Usuki, Takayuki Tanaka, Takehiko Mori, Satoshi Wakita, Toshiki I Saito, Akiko M Saito, Kazuya Shimoda, Toshiro Kurokawa, Akihiro Tomita, Hitoshi Kiyoi, Koichi Akashi, Itaru Matsumura, Katsuto Takenaka, Norio Komatsu, Kohshi Ohishi, Isao Tawara, Yuka Sugimoto
Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysis. Annals of hematology 103 (9) (2024)
Emily R Cox, Corinne Summers, Filippo Milano, Ann Dahlberg, Marie Bleakley, Brenda M Sandmaier, Monica S Thakar
Outcomes of patients undergoing third hematopoietic cell transplantation for hematologic malignancies. Annals of hematology 103 (9) (2024)
Fei Chen
ETV6::ABL1 positive myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions (MLN-TK) with blast crisis treated with flumatinib mesylate. Annals of hematology 103 (9) (2024)
Taku Kikuchi, Nobuhiro Tsukada, Kodai Kunisada, Chiaki Matsumoto, Moe Nomura-Yogo, Yuki Oda, Kota Sato, Tomomi Takei, Mizuki Ogura, Yu Abe, Kenshi Suzuki, Osamu Hosoya, Tadao Ishida
Prognostic impact of 1q abnormality on outcomes in patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide and dexamethasone in a real-world clinical setting. Annals of hematology 103 (9) (2024)
Qingwei Wang, Yixin Hu, Li Gao, Senlin Zhang, Jun Lu, Bohan Li, Jie Li, Yanhua Yao, Shengqin Cheng, Shao-Yan Hu, Shaoyan Hu
Pediatric acute myeloid leukemia with t(8;21) and KIT mutation treatment with avapritinib post-stem cell transplantation: a report of four cases. Annals of hematology 103 (9) (2024)
Bingwen Eugene Fan, Minyang Chow
Artificial intelligence assisted diagnosis of chronic lymphocytic leukemia in a historic pediatric case using large language models. Annals of hematology 103 (9) (2024)
Zerong Wang, Xuelian Jin, Jiajia Zeng, Zilin Xiong, Xinchuan Chen
The application of JAK inhibitors in the peri-transplantation period of hematopoietic stem cell transplantation for myelofibrosis. Annals of hematology 103 (9) (2024)
Rina Hosoda, Yoshinori Hashimoto, Kentaro Hara, Masaya Maegaki, Sayaka Suzuki, Yuzuru Hosoda, Koji Kawamura
Disappearance of a chromosomal abnormality in a young patient with polycythemia vera treated with ropeginterferon alfa-2b. Annals of hematology 103 (9) (2024)
Yiyi Lu, Lin Lin, Jiafei Lin, Beiying Wu, Gang Cai, Xuefeng Wang, Xuefei Ma
Superior detection of low-allele burden Janus kinase 2 V617F mutation and monitoring clonal evolution in myeloproliferative neoplasms using chip-based digital PCR. Annals of hematology 103 (9) (2024)
Massimo Breccia, Tiziano Barbui
Equitable access to polycythemia vera treatments: addressing reimbursement disparities in Europe. Annals of hematology 103 (9) (2024)
Yu Zhao, Yun Huang, Ling Jiang, Yujiao Zhang, Fang Liu, Ping Yan, Guopan Yu, Jiajun Liu, Xuejie Jiang
Impact of different CEBPA mutations on therapeutic outcome in acute myeloid leukemia. Annals of hematology 103 (9) (2024)
Yuanfei Shi, Yi Xu, Huafei Shen, Jie Jin, Hongyan Tong, Wanzhuo Xie
Advances in biology, diagnosis and treatment of DLBCL. Annals of hematology 103 (9) (2024)
Dina N Laimon, Doaa H Sakr, Basma Atef, Yasmine Shaaban
Highlights of ophthalmological manifestations in newly diagnosed acute leukemia: a correlation with hematological parameters. Annals of hematology 103 (9) (2024)
Eman Mahmoud Ezzat, Salwa Bakr, Rehab M Golam, Basma Atiya Abdelgyed, Nourhan Mohamed Nasr
Adipocyte fatty acid-binding protein (FABP4) as a potential biomarker for predicting metabolically driven low-grade and organ damage in thalassemia syndromes. Annals of hematology 103 (9) (2024)
Songphol Tungjitviboonkun, Naharuthai Bumrungratanayos, Jedsadakorn Jitwimungsanon, Thanat Kheamakulvanich, Smuch Siramongkholkarn
Efficacy and safety of fostamatinib in refractory immune thrombocytopenia: a meta-analysis from randomized controlled trials. Annals of hematology 103 (9) (2024)
Zhengrui Xiao, Zhiqiang He, Hieu Liem Le Nguyen, Rahul Kumar Thakur, M Bakri Hammami, Hiba Narvel, Charan Thej Reddy Vegivinti, Noelle Townsend, Henny Billett, Irina Murakhovskaya
Obesity is associated with adverse outcomes in primary immune thrombocytopenia - a retrospective single-center study. Annals of hematology 103 (9) (2024)
Dongfei Yin, Jingshi Wang, Zhao Wang
The effectiveness of the doxorubicin-etoposide-methylprednisolone regimen for adult HLH secondary to rheumatic disease. Annals of hematology 103 (9) (2024)
Valentina Maria Manieri, Massimo Offidani, Debora Capelli, Marco Marzioni, Luca Maroni, Alessandra Filosa, Serena Rupoli, Erika Morsia, Antonella Poloni, Sonia Morè
Hepatic, gastric and bone marrow AL amyloidosis that began with Budd-Chiari syndrome: a case report. Annals of hematology 103 (9) (2024)
Xiao-Tong Huang, Chan-Juan Wang, Chao Gao, Tian-Lin Xue, Zi-Jing Zhao, Tian-You Wang, Min-Yuan Wu, Lei Cui, Rui-Dong Zhang, Zhi-Gang Li
Relationship between subtype-specific minimal residual disease level and long-term prognosis in children with acute lymphoblastic leukemia. Annals of hematology 103 (9) (2024)
Salvatore Leotta, Uros Markovic, Andrea Duminuco, Antonino Mulè, Ferdinando Porretto, Vincenzo Federico, Massimo Gentile, Domenico Pastore, Luca Lo Nigro, Carmine Selleri, Bianca Serio, Valeria Calafiore, Caterina Patti, Elisa Mauro, Calogero Vetro, Cinzia Maugeri, Marina Parisi, Paolo Fiumara, Laura Parrinello, Sara Marino, Grazia Scuderi, Bruno Garibaldi, Maurizio Musso, Nicola Di Renzo, Ernesto Vigna, Enrica Antonia Martino, Francesco Di Raimondo, Giuseppe Milone
Impact of minimal residual disease response and of status of disease on survival after blinatumomab in B-cell acute lymphoblastic leukemia: results from a real-life study. Annals of hematology 103 (9) (2024)
Jingjing Deng, Xiaoqi Qin, Guangyu Ma, Xuliang Shen, Jingnan Sun, Yanhong Zhao, Zhihua Zhang, Ying Sun, Guitao Jie, Liping Su, Jie Ma, Weiwei Tian, Lin Yang, Qingming Wang, Hongming Huang, Mingxia Shi, Yanping Ma, Wen Gao, Wenming Chen
Development of a clinical prognostic model for primary plasma cell leukemia patients treated with novel agents: a multicenter retrospective cohort study. Annals of hematology 103 (9) (2024)
Jia Chen, Ming-Nan Jia, Hao Cai, Ze-Peng Li, Jian Li, Dao-Bin Zhou, Xin-Xin Cao
Serum CXCL13 level is related to treatment response and predicts disease prognosis in Waldenström macroglobulinemia. Annals of hematology 103 (9) (2024)
Shijia Cheng, Zheng Yan, Hongxia Ma, Yanyan Liu
Lymphoma-associated hemophagocytic syndrome: a retrospective, single-center study of 86 patients. Annals of hematology 103 (9) (2024)
Tadeusz Robak, Anna Puła, Marcin Braun, Ewa Robak
Extramedullary and extranodal manifestations in chronic lymphocytic leukemia - an update. Annals of hematology 103 (9) (2024)
Despina Fotiou, Eirini Solia, Foteini Theodorakakou, Panagiota Nikolaou, Charikleia Gakiopoulou, Erasmia Psimenou, Asimina Papanikolaou, Meletios A Dimopoulos, Efstathios Kastritis
TEMPI syndrome: difficult to diagnose, "easy" to treat? Annals of hematology 103 (9) (2024)
Fayyaz Hussain, Mussawair Hussain, Asghar Ali Kerio, Tariq Ghafoor, Tariq Azam Khattak, Qamar Un Nisa Chaudhry, Nighat Shahbaz, Mehreen Ali Khan, Raheel Iftikhar
Allogeneic stem cell transplant in primary hemophagocytic lymphohistiocytosis - a single-center experience. Annals of hematology 103 (9) (2024)
John Yan, M Bakri Hammami, John X Wei, Nishi Shah, Mendel Goldfinger, Ioannis Mantzaris, Noah Kornblum, Kira Gritsman, Alejandro Sica, Dennis Cooper, Eric Feldman, Marina Konopleva, Kith Pradhan, Rahul Thakur, Charan Vegivinti, Asma Qasim, Amit Verma, Swati Goel
Socio-demographic determinants of myelofibrosis outcomes in an underserved center and the SEER national database. Annals of hematology 103 (9) (2024)
Luca Guarnera, Maria Rosaria Pascale, Hajro Hajrullaj, Antonio Cristiano, Flavia Mallegni, Angelo Onorato, Maria Teresa Voso, Emiliano Fabiani
The role of clonal progression leading to the development of therapy-related myeloid neoplasms. Annals of hematology 103 (9) (2024)
Olga Mulas, Fabio Efficace, Alessandro Costa, Thomas Baldi, Filippo Zerbini, Daniela Mantovani, Emanuela Morelli, Daniela Perra, Giorgio La Nasa, Giovanni Caocci
Response to Dr. Ying Cui comments. Annals of hematology 103 (9) (2024)
Jeffrey H Lipton, Tim H Brümmendorf, Kendra Sweet, Jane F Apperley, Jorge E Cortes
Practical considerations in the management of patients treated with bosutinib for chronic myeloid leukemia. Annals of hematology 103 (9) (2024)
Luca Guarnera, Ilaria Tiravanti, Arianna Guiducci, Luigi Coppola, Massimiliano Marinoni, Andrea Nunzi, Roberta Laureana, Lucia Cardillo, Fabiana Esposito, Roberto Secchi, Elisa Buzzatti, Giovangiacinto Paterno, Livio Pupo, Loredana Sarmati, Valter Gattei, Adriano Venditti, Massimiliano Postorino, Maria Ilaria Del Principe
Prophylaxis with Tixagevimab/Cilgavimab in chronic lymphocytic leukaemia, a case control study. Annals of hematology 103 (9) (2024)
Wenxi Hua, Jiaqian Qi, Meng Zhou, Shiyu Han, Xiaoyan Xu, Jinwen Su, Tingting Pan, Depei Wu, Yue Han
Overexpression of REC8 induces aberrant gamete meiotic division and contributes to AML pathogenesis - a multiplexed microarray analysis and mendelian randomization study. Annals of hematology 103 (9) (2024)
Fatma Soliman Elsayed Ebeid, Nihal Hussien Aly, Naglaa Mohammed Shaheen, Samah Mohammed Ahmed Abdellatif, Ahmed Ashraf Mahmoud Okba, Nada Ayman Gad, Sara Mostafa Makkeyah
Safety and efficacy of L-Glutamine in reducing the frequency of acute complications among patients with sickle cell disease: A randomized controlled study. Annals of hematology 103 (9) (2024)
Kohei Shiroshita
Does R-EPOCH reduce the incidence of pulmonary embolism in cardiac lymphoma? Annals of hematology 103 (9) (2024)
Ekta Jajodia, Hemant Menghani, Neeraj Arora, Ankit Jitani
De-novo ATR-16 syndrome associated with inherited hemoglobin Evanston causing HbH phenotype: a rare occurrence. Annals of hematology 103 (9) (2024)
Bin Chu, Yu-Tong Wang, Shan Gao, Lei Shi, Min-Qiu Lu, Li-Juan Fang, Qiu-Qing Xiang, Yuan Chen, Meng-Zhen Wang, Li-Fang Wang, Kai Sun, Jing Yang, Fangfang Duan, Li Bao
R2-ISS staging combined with circulating plasma cells improves risk stratification for newly diagnosed multiple myeloma: a single-center real-world study. Annals of hematology 103 (9) (2024)
Xiaoli Li, Xiaohui Shangguan, Hong Wang, Qingyuan Wang, Yanming Zhang, Bing Han, Rongrong Liu, Fengkui Zhang, Rong Fu, Zenghua Lin, Miao Miao, Xiao Ma, Meiqing Lei, Depei Wu, Limin Liu
Comparison of efficacy of eltrombopag combined with immunosuppression in the treatment of severe aplastic anemia and very severe aplastic anemia: real-world data and evidence. Annals of hematology 103 (9) (2024)
Alon Rozental, Erez Halperin, Chiya Leibovitch, Meirav Barzili, Maya Koren- Michowitz, Adrian Duek, Uri Rozovski, Martine Extermann, Pia Raanani, Adi Shacham-Abulafia
CML in the very elderly: the impact of comorbidities and TKI selection in a real-life multicenter study. Annals of hematology 103 (9) (2024)
Xie Juan, Zeying Fan, Xunhong Cao, Yi-Yang Ding, Huixin Liu, Qian-Nan Shang, Xiaosu Zhao, Yingjun Chang, Yu Wang, Lanping Xu, Xiaohui Zhang, Xiaojun Huang, Xiangyu Zhao
CD56 bright NK cell expansion correlated with EBV reactivation control post allogeneic hematopoietic stem cell transplantation. Annals of hematology 103 (9) (2024)
Seok Jin Kim, Seug Yun Yoon, Sharon Chua, Hyeran Byun, Jiyoon Kim, Junice Ng
Delphi consensus recommendations on treatment for advanced-stage marginal zone lymphoma in South Korea. Annals of hematology 103 (9) (2024)
Mirza Faris Ali Baig, Kalyan Chaliki
Inpatient outcomes of NSTEMI among patients with immune thrombocytopenia: a propensity matched national study. Annals of hematology 103 (9) (2024)
Leyu Wang, Liwei Fang, Hongxia Shi, Yinghui Liu, Chan Long, Shuxia Guo, Xiuli Yang, Qinglin Hu, Ziwei Liu, Chen Yang, Miao Chen, Bing Han
Treatment of myelofibrosis with refractory anemia with luspatercept: a multicenter Chinese study. Annals of hematology 103 (9) (2024)
Yanyan Zhang, Fen He, Wei Hu, Jingqi Sun, Hongyan Zhao, Yuzhi Cheng, Zhanyou Tang, Jiarui He, Xiangyuan Wang, Tairan Liu, Cong Luo, Zhongwei Lu, Mei Xiang, Yiting Liao, Yihao Wang, Junjun Li, Jiliang Xia
Bortezomib elevates intracellular free Fe 2+ by enhancing NCOA4-mediated ferritinophagy and synergizes with RSL-3 to inhibit multiple myeloma cells. Annals of hematology 103 (9) (2024)
Jiawang Ou, Shiyu Deng, Chenhao Ding, Zihong Cai, Junjie Chen, Zicong Huang, Xiuli Xu, Jia Li, Zhengwei Wu, Bingqing Tang, Ting Zhang, Zhixiang Wang, Ya Zhou, Li Xuan, Qifa Liu, Hongsheng Zhou
Mutations of epigenetic modifier genes predict poor outcome in adult acute lymphoblastic leukemia. Annals of hematology 103 (9) (2024)
Lijuan Hu, Zongru Li, Sen Yang, Ting Zhao, Wenbing Duan, Yazhen Qin, Jinsong Jia, Jing Wang, Shengye Lu, Hao Jiang, Xiaohui Zhang, Lanping Xu, Yu Wang, Yueyun Lai, Hongxia Shi, Xiaojun Huang, Qian Jiang
Allogeneic stem cell transplantation is still a highly curative therapy in adults with philadelphia chromosome-positive acute lymphoblastic leukaemia. Annals of hematology 103 (9) (2024)